Axogen, Inc. — Director's Dealing 2026

Mar 3, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2026-02-26

Reporting Person: DeVinney Erick Wayne (Chief Innovation Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-26	Common Stock	A	33780	—	Acquired	274912	Direct
2026-02-26	Common Stock	F	10702	$31.90	Disposed	264210	Direct
2026-03-01	Common Stock	F	11276	$30.65	Disposed	252934	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-26	Restricted Stock Units	$	A	23000	Acquired		Common Stock (23000)	Direct

Footnotes

F1: This reflects the number of shares that became vested as of February 26, 2026, upon the attainment and certification of certain performance criteria.

F2: No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of performance stock units ("PSUs").

F3: No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of restricted stock units ("RSUs").

F4: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F5: All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.